DK189584D0 - (5alfa)-20-spirox-1-en-3-oner samt deres fremstilling og anvendelse - Google Patents

(5alfa)-20-spirox-1-en-3-oner samt deres fremstilling og anvendelse

Info

Publication number
DK189584D0
DK189584D0 DK1895/84A DK189584A DK189584D0 DK 189584 D0 DK189584 D0 DK 189584D0 DK 1895/84 A DK1895/84 A DK 1895/84A DK 189584 A DK189584 A DK 189584A DK 189584 D0 DK189584 D0 DK 189584D0
Authority
DK
Denmark
Prior art keywords
5alfa
spirox
oner
preparation
Prior art date
Application number
DK1895/84A
Other languages
English (en)
Other versions
DK189584A (da
Inventor
Juergen Grob
Jaroslav Kalvoda
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DK189584D0 publication Critical patent/DK189584D0/da
Publication of DK189584A publication Critical patent/DK189584A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C07J71/0015—Oxiranes at position 9(11)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/001—Lactones
    • C07J21/003—Lactones at position 17

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK189584A 1983-04-13 1984-04-12 (5alfa)-20-spirox-1-en-3-oner samt deres fremstilling og anvendelse DK189584A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH197983 1983-04-13
CH197983 1983-04-13

Publications (2)

Publication Number Publication Date
DK189584D0 true DK189584D0 (da) 1984-04-12
DK189584A DK189584A (da) 1984-10-14

Family

ID=4223075

Family Applications (1)

Application Number Title Priority Date Filing Date
DK189584A DK189584A (da) 1983-04-13 1984-04-12 (5alfa)-20-spirox-1-en-3-oner samt deres fremstilling og anvendelse

Country Status (6)

Country Link
US (1) US4552871A (da)
EP (1) EP0122882A1 (da)
JP (1) JPS59205400A (da)
AU (1) AU2685284A (da)
DK (1) DK189584A (da)
ES (1) ES8602845A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6372712B1 (en) 1998-05-22 2002-04-16 The Board Of Trustees Of The Leland Stanford Jr. University Synthetic bifunctional molecules containing a drug moiety and presenter protein ligand
WO2003049745A1 (en) 2001-12-12 2003-06-19 Pharmacia Corporation Method of treating ophthalmic disorders with epoxy-steroidal aldosterone receptor antagonists
EP2671508B1 (en) 2005-04-28 2020-09-16 Proteus Digital Health, Inc. Pharma-informatics system
US9062126B2 (en) 2005-09-16 2015-06-23 Raptor Pharmaceuticals Inc. Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
ES2919563T3 (es) 2009-02-20 2022-07-27 Enhanx Biopharm Inc Sistema de administración de medicamentos a base de glutatión
KR20180114970A (ko) 2009-05-06 2018-10-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3095412A (en) * 1961-12-19 1963-06-25 Searle & Co 9alpha, 11alpha-epoxy and 11beta-chloro-9alpha-hydroxy 17alpha-(2-carboxyethyl)-17beta-hydroxyandrost-4-en-3-one gamma-lactones and delta1 and delta6 analogs
GB1368731A (en) * 1972-01-24 1974-10-02 Searle & Co 9alpha 11alpha-epoxy spirolactones and corresponding spirolactols and lactol ethers
IE44711B1 (en) * 1976-03-05 1982-03-10 Schering Ag 17 -hydroxypropyl-4-3-keto-steroids and esters thereof, and process for their manufacture
US4079054A (en) * 1976-12-22 1978-03-14 Schering Corporation 7α-Halogeno-3-oxo-1,4-pregnadiene-21,17β-carbolactones and related compounds

Also Published As

Publication number Publication date
JPS59205400A (ja) 1984-11-20
EP0122882A1 (de) 1984-10-24
ES531516A0 (es) 1985-12-01
US4552871A (en) 1985-11-12
DK189584A (da) 1984-10-14
ES8602845A1 (es) 1985-12-01
AU2685284A (en) 1984-10-18

Similar Documents

Publication Publication Date Title
DK41484A (da) Beta-phenethanolaminer og deres anvendelse
DK559985D0 (da) 13beta-milbemycinderivater samt deres fremstilling og anvendelse
DK554784D0 (da) Substituerede 5-amino-4-hydroxyvalerylderivater samt deres fremstilling og anvendelse
DK420785D0 (da) 13-halogen- eller 13-hydroxymilbemyciner samt deres fremstilling og anvendelse
DK578185A (da) 13beta-milbemycinderivater samt deres fremstilling og anvendelse
DK35884A (da) Lactampeptider samt deres fremstilling og anvendelse
DK614084A (da) Milbemycim-derivater samt deres fremstilling og anvendelse
DK614384A (da) Substituerede imidazoler samt deres fremstilling og anvendelse
DK294684D0 (da) N-alkylerede 3-phenyl-4-cyanopyrrol-derivater samt deres fremstilling og anvendelse
DK280085D0 (da) 7alfa-acylthio-9alfa,11alfa-epoxy-20-spirox-4-en-3,21-dioner samt deresfremstilling og anvendelse
DK537785A (da) Flavolignanderivater samt deres fremstilling og anvendelse
DK558484A (da) Milbemycinderivater samt deres fremstilling og anvendelse
DK419084A (da) 2-aminomethyl-2-penem-forbindelser samt deres fremstilling og anvendelse
DK393285A (da) Substituerede carbonylphenylsulfonylguanidiner samt deres fremstilling og anvendelse
DK236585A (da) Acylerede hexosederivater samt deres fremstilling og anvendelse
DK358882A (da) Anthracyclinantibiotica samt deres fremstilling og anvendelse
DK35984D0 (da) Lactampeptider samt deres fremstilling og anvendelse
DK522883D0 (da) 2-heterocyclythio-alkyl-2-penem-forbindelser samt deres fremstilling og anvendelse
DK613984D0 (da) 2-heterocyclyl-6-hydroxylavalkyl-2-penem-forbindelser samt deres fremstilling og anvendelse
DK422685D0 (da) Benzazolderivater samt deres fremstilling og anvendelse
DK162607C (da) Azopigmentpraeparater og deres anvendelse
DK153285D0 (da) Benzodioxolderivater samt deres fremstilling og anvendelse
DK361185D0 (da) 2-aminoalkyl-2-penem-forbindelser samt deres fremstilling og anvendelse
DK381784D0 (da) Acylerede hydrazinforbindelser samt deres fremstilling og anvendelse
DK174684D0 (da) 7beta-acylamido-3-cephem-4-carboxylsyreforbindelser samt deres fremstilling og anvendelse

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment
AHS Application shelved for other reasons than non-payment